The results of the measurement of vitamin B12 absorption by counting the radioactivity of 5 ml. serum obtained eight to 10 hours after the ingestion of an oral dose of 0 5 ,tg. vitamin B12 labelled with 0-5 ,uc. 57Co are compared with those obtained with the urinary excretion (Schilling) test. Inadequate urine collection and impaired renal function were responsible for low results in the Schilling test in four of the 12 control subjects, and an incomplete urine collection in four patients with pernicious anaemia could have led to doubt about the validity of the low result. It is necessary to measure the absorption of vitamin B12 from the small intestine in order to diagnose the cause of vitamin B12 deficiency with precision. The methods available for measuring the absorption of an oral dose of radioactive vitamin B12 include the estimation of radioactivity in the faeces (Heinle, Welch, Scharf, Meacham, and Prusoff, 1952) , the urine (Schilling, 1953) , the liver (Glass and Boyd, 1957) , and the blood (Booth and Mollin, 1956) . Before measuring the hepatic uptake of vitamin B12 the residual radioactivity in the bowel must be cleared by laxatives and an enema, and in the faecal excretion method the preparation of the specimens is unpleasant and it takes an average of seven days to complete the test. Because of these disadvantages the measurement of the excretion of radioactivity in the urine (Schilling test) has been the most widely adopted method. However, the Schilling test also has disadvantages: these are that the test depends upon renal function and a complete 24-hour urine collection, and that the large parenteral dose of non-radioactive vitamin B12 may occasionally obscure the diagnosis.
It is necessary to measure the absorption of vitamin B12 from the small intestine in order to diagnose the cause of vitamin B12 deficiency with precision. The methods available for measuring the absorption of an oral dose of radioactive vitamin B12 include the estimation of radioactivity in the faeces (Heinle, Welch, Scharf, Meacham, and Prusoff, 1952) , the urine (Schilling, 1953) , the liver (Glass and Boyd, 1957) , and the blood (Booth and Mollin, 1956) . Before measuring the hepatic uptake of vitamin B12 the residual radioactivity in the bowel must be cleared by laxatives and an enema, and in the faecal excretion method the preparation of the specimens is unpleasant and it takes an average of seven days to complete the test. Because of these disadvantages the measurement of the excretion of radioactivity in the urine (Schilling test) has been the most widely adopted method. However, the Schilling test also has disadvantages: these are that the test depends upon renal function and a complete 24-hour urine collection, and that the large parenteral dose of non-radioactive vitamin B12 may occasionally obscure the diagnosis.
The measurement of radioactivity in a single
Received for publication 9 May 1966. sample of serum or plasma is clearly the simplest method. However, the amount of radioactivity that appears in the blood after oral doses of 0 5 to 1-0 ,ug. vitamine B12 is small and in the early studies in which vitamin B12 labelled with -"Co, 58Co, or 6OCo was used it was necessary either to obtain large quantities of serum or plasma, to count for long periods in very sensitive scintillation counters, or to use isotopes of high specific activity (Booth and Mollin, 1956; Doscherholmen and Hagen, 1957; Goldberg, Trivedi, and Oliver, 1957) . In view of these disadvantages the counting of radioactivity in the blood was not regarded as a satisfactory method for measuring vitamin B12 absorption. However, the lower energy gamma radiation of 57Co is counted with high efficiency by scintillation crystals (Eberle and Gleason, 1960) , and when vitamin B12 labelled with 57Co became available, blood counting was again investigated and satisfactory results were obtained using a dose of 0.5 ,uc. and a small volume of serum (Nelp, McAfee, and Wagner, 1963; McCurdy, 1965 (Matthews, 1962) , and of folic acid activity by the Lactobacillus casei method (Spray, 1964) . The normal range of the level of serum vitamin B12 is 150 to 850 pg. per ml., and of folic acid activity 2-1 to 12 ng. per ml.
The intestinal absorption of 0-5 ,ug. vitamin B12 labelled with 0-5 uc. "7Co was measured. The oral dose of radioactive vitamin B12 was accompanied by either an intramuscular injection of 0-04 mg. histamine per kilogram of body weight or, if vitamin B12 absorption with histamine was low, by an oral dose of 60 mg. intrinsic factor preparation (Armour). The side-effects of histamine were prevented by giving an intramuscular injection of 100 mg. mepyramine beforehand. Two hours later a parenteral dose of 1 mg. non-radioactive vitamin B12 was given. The urine was collected for 24 hours and a 5 ml. sample of serum obtained between eight and 10 hours after the dose of radioactive vitamin B12, as it has been shown that blood radioactivity reaches a maximum concentration at this time (Doscherholmen and Hagen, 1957 ).
An Ekco well-type scintillation counter (N664A) crystal (N597) and scaler (N610B) were used. Background counts were recorded for 1,000 seconds both before and after counting the samples. Three 5 ml. aliquots from each 24-hour collection of urine were counted for 300 seconds, and the 5 ml. samples of sera were counted for 1,000 seconds. The radioactivity in the urine was expressed as a percentage of the administered dose. There was little variation in the radioactivity of the doses of 57Co vitamin B12, and the serum radioactivity was therefore recorded directly as counts (serum counts minus background counts) per minute per 5 m-l. When the serum radioactivity was in the marginal range (17 to 25 counts per minute) both the background and serum counting were repeated for a further 1,000 seconds.
RESULTS
The background radioactivity before and after counting each batch of urine and serum samples was fairly constant. During the period of this investigation, in which 19 batches of samples were counted, the background radioactivity ranged from 73 to 88 counts per minute (mean 80-8 c.p.m.). Before deducting the background counts, the level of radioactivity in the serum samples from the 12 control patients ranged from 105 to 147 counts per minute (mean 123-2 + 8-2 c.p.m.), while levels in the 10 patients with pernicious anaemia ranged from 76 to 101 counts per minute (mean 87-6 ± 5-2 c.p.m.).
Using a t test these differences were found to be significant at the 0-1 % level.
The results are summarized in Tables I and II . In the 12 control subjects believed to have normal vitamin B12 absorption, the 24-hour urinary excretion of radioactivity was 6 to 29 % of the administered dose, and the serum radioactivity was between 28 and 64 counts per minute. The urine contained less than 11 % of the dose in four subjects, and this is below the normal range when a dose of 0 5 ,ug. vitamin B12 is used (Callender and Evans, 1955) . One of these patients (no. 12), in whom only 6% of the administered radioactivity was excreted in the urine, had chronic pyelonephritis and the blood urea level was 250 mg. per 100 ml. In another patient (no. 7) only 200 ml. urine was collected, and in the other two patients (nos. 2 and 4) the small urine volumes suggest that these collections were also incomplete. In the 10 patients with pernicious anaemia the excretion of radioactivity in the urine ranged from less than 1 % to 8 %, and eight of the results were below 6%. For these patients serum radioactivity was from 0 to 19 counts per minute. When the tests were repeated with intrinsic factor, the radioactivity in the urine was from 10 to 24 %, and in the serum from 24 to 47 counts per minute.
Two patients with idiopathic steatorrhoea (nos. 23 and 24) had normal vitamin B12 absorption, the radioactivity in the urine being 12 and 14% and in the serum 34 and 41 counts per minute. In the other two patients with idiopathic steatorrhoea (nos. 25 and 26) there was evidence of impaired absorption of vitamin B12; the radioactivity in the urine was 8 % in both patients, and the serum counts were 16 and 14 per minute. The test was repeated with intrinsic factor in one patient (no. 25) with no improvement, J. Forshaw and Lilian Harwood Two patients with nutritional megaloblastic anaemia had normal vitamin B12 absorption; the radioactivity in the urine was 30 and 18 %, and in the serum 47 and 36 counts per minute. In one patient (no. 27) with megaloblastic anaemia following a partial gastrectomy, and in whom the serum vitamin B12 was 100 pg. per ml. and serum folic acid activity 1-5 ng. per ml., the excretion of radioactivity in the urine was only 5 %, but the serum counts were 24 per minute. These figures rose to 12 % and 34 counts per minute with intrinsic factor. The small collection of urine in this case suggests that the serum radioactivity was better than the urinary radioactivity as a measurement of vitamin B12 absorption, and the serum counts indicate only a partial deficiency of intrinsic factor.
DISCUSSION
An accurate result with the Schilling test depends on normal renal function and a complete collection of urine during a period of 24 hours. This is often impossible to achieve with unreliable elderly patients in an understaffed busy medical ward, and not infrequently the results of the Schilling tests were misleading. The radioactivity in the urine was low in four of the 12 control subjects as a result of an incomplete urine collection in three cases and impaired renal function in one case. Conversely the significance of a low result in a case of megaloblastic anaemia is uncertain when the collection of urine is probably incomplete, and this situation occurred in four patients with pernicious anaemia. 
